Institute of Orthopaedics, Beijing Key Lab of Regenerative Medicine in Orthopaedics, Chinese PLA General Hospital, Beijing, 100583, China.
Zhoushan Dinghai Guanghua Hospital, Zhoushan, 316000, China.
Mil Med Res. 2021 Mar 9;8(1):18. doi: 10.1186/s40779-021-00308-5.
Vacuum sealing drainage (VSD) and epidermal growth factor (EGF) both play an important role in the treatment of wounds. This study aims to explore the effects of the combination of VSD and EGF on wound healing and the optimal concentration and time of EGF.
We tested the proliferation and migration capacity of HaCaT and L929 cells at different EGF concentrations (0, 1, 5, 10, and 100 ng/ml) and different EGF action times (2, 10, and 30 min). A full-thickness skin defect model was established using male, 30-week-old Bama pigs. The experiment included groups as follows: routine dressing change after covering with sterile auxiliary material (Control), continuous negative pressure drainage of the wound (VSD), continuous negative pressure drainage of the wound and injection of EGF 10 min followed by removal by continuous lavage (V + E 10 min), and continuous negative pressure drainage of the wound and injection of EGF 30 min followed by removal by continuous lavage (V + E 30 min). The wound healing rate, histological repair effect and collagen deposition were compared among the four groups.
An EGF concentration of 10 ng/ml and an action time of 10 min had optimal effects on the proliferation and migration capacities of HaCaT and L929 cells. The drug dispersion effect was better than drug infusion after bolus injection effect, and the contact surface was wider. Compared with other groups, the V + E 10 min group promoted wound healing to the greatest extent and obtained the best histological score.
A recombinant human epidermal growth factor (rhEGF) concentration of 10 ng/ml can promote the proliferation and migration of epithelial cells and fibroblasts to the greatest extent in vitro. VSD combined with rhEGF kept in place for 10 min and then washed, can promote wound healing better than the other treatments in vivo.
负压封闭引流(VSD)和表皮生长因子(EGF)在创面治疗中均发挥重要作用。本研究旨在探讨 VSD 联合 EGF 对创面愈合的影响以及 EGF 的最佳浓度和时间。
我们在不同 EGF 浓度(0、1、5、10 和 100ng/ml)和不同 EGF 作用时间(2、10 和 30min)下测试 HaCaT 和 L929 细胞的增殖和迁移能力。使用雄性、30 周龄巴马猪建立全层皮肤缺损模型。实验分组如下:覆盖无菌辅料后常规换药(对照)、创面持续负压引流(VSD)、创面持续负压引流并于 10min 时注射 EGF 后持续冲洗去除(V+E 10min)、创面持续负压引流并于 30min 时注射 EGF 后持续冲洗去除(V+E 30min)。比较四组的创面愈合率、组织学修复效果和胶原沉积。
EGF 浓度为 10ng/ml、作用时间为 10min 对 HaCaT 和 L929 细胞的增殖和迁移能力有最佳作用。与药物推注效果相比,药物灌注效果更好,药物扩散更均匀,接触面积更宽。与其他组相比,V+E 10min 组促进创面愈合的效果最大,获得的组织学评分最好。
重组人表皮生长因子(rhEGF)浓度为 10ng/ml 可最大程度促进体外上皮细胞和成纤维细胞的增殖和迁移。VSD 联合留置 10min 后冲洗去除的 rhEGF 能更好地促进体内创面愈合。